
This article explores the emergence of subjectivity in ICH Q9 (R1).
Martin J. Lipa, PhD, martin.lipa@prst.ie, is a senior research fellow at Pharmaceutical Regulatory Science Team.

This article explores the emergence of subjectivity in ICH Q9 (R1).

Recent research and perspectives shed light on an opportunity to better connect risk and knowledge through improved integration of systems.

Recent research and perspectives shed light on an opportunity to better connect risk and knowledge through improved integration of systems.

Published: January 15th 2024 | Updated:

Published: September 3rd 2023 | Updated:

Published: March 3rd 2024 | Updated: